Abstract: A system is provided. The system includes a C-arm with an X-ray source and an X-ray detector mounted thereon opposite each other. The system also includes a carrier coupled to the C-arm and configured to rotate the C-arm relative to the carrier. The system further includes a base and a multiple robotic arms coupling the carrier to the base. Each robotic arm of the multiple robotic arms includes two articulated segments and at least two rotary joints.

Abstract: Immunoapheresis treatment for cardiomyopathy comprises passing the patient's plasma over a column having coupled thereto a specific ligand for human immunoglobulin, thereby removing a significant portion of the immunoglobulin from the patient's plasma, and then reinfusing the plasma to the patient. The invention is the use of a specific ligand for human immunoglobulin in the manufacture of a column having the ligand coupled thereto, the column being useful for immunoapheresis treatment of a patient with cardiomyopathy. The specific ligand binds, and thereby removes, human autoantibodies which are harmful to cardiac tissue such as antibodies against ?1-adrenergic receptors, ADP-ATP carriers, ? and ? myosin heavy chains, and adenine nucleotide translocators.

Abstract: Immunoapheresis treatment for cardiomyopathy comprises passing the patient's plasma over a column having coupled thereto a specific ligand for human immunoglobulin, thereby removing a significant portion of the immunoglobulin from the patient's plasma, and then reinfusing the plasma to the patient. The invention is the use of a specific ligand for human immunoglobulin in the manufacture of a column having the ligand coupled thereto, the column being useful for immunoapheresis treatment of a patient with cardiomyopathy. The specific ligand binds, and thereby removes, human autoantibodies which are harmful to cardiac tissue such as antibodies against &bgr;1-adrenergic receptors, ADP-ATP carriers, &agr; and &bgr; myosin heavy chains, and adenine nucleotide translocators.